Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bioventus (BVS) Other Operating Expenses (2023 - 2025)

Bioventus filings provide 3 years of Other Operating Expenses readings, the most recent being $1000.0 for Q3 2025.

  • On a quarterly basis, Other Operating Expenses changed N/A to $1000.0 in Q3 2025 year-over-year; TTM through Dec 2025 was -$81000.0, a 72.26% increase, with the full-year FY2025 number at -$81000.0, up 72.26% from a year prior.
  • Other Operating Expenses hit $1000.0 in Q3 2025 for Bioventus, up from -$1000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $1000.0 in Q3 2025 to a low of -$1.4 million in Q3 2023.
  • Median Other Operating Expenses over the past 3 years was -$292000.0 (2024), compared with a mean of -$564285.7.
  • The widest YoY moves for Other Operating Expenses: up 75.59% in 2024, down 75.59% in 2024.
  • Bioventus' Other Operating Expenses stood at -$1.2 million in 2023, then surged by 75.59% to -$292000.0 in 2024, then soared by 100.34% to $1000.0 in 2025.
  • The last three reported values for Other Operating Expenses were $1000.0 (Q3 2025), -$1000.0 (Q2 2025), and -$81000.0 (Q1 2025) per Business Quant data.